Effect of solvent type on the nanoparticle formation of atorvastatin calcium by the supercritical antisolvent process

Min Soo Kim, Ha Seung Song, Hee Jun Park, Sung Joo Hwang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The aims of this study were to identify how the solvent selection affects particle formation and to examine the effect of the initial drug solution concentration on mean particle size and particle size distribution in the supercritical antisolvent (SAS) process. Amorphous atorvastatin calcium was precipitated from seven different solvents using the SAS process. Particles with mean particle size ranging between 62.6 and 1493.7 nm were obtained by varying organic solvent type and solution concentration. By changing the solvent, we observed large variations in particle size and particle size distribution, accompanied by different particle morphologies. Particles obtained from acetone and tetrahydrofuran (THF) were compact and spherical fine particles, whereas those from N-methylpyrrolidone (NMP) and dimethylsulfoxide (DMSO) were agglomerated, with rough surfaces and relatively larger particle sizes. Interestingly, the mean particle size of atorvastatin calcium increased with an increase in the boiling point of the organic solvent used. Thus, for atorvastatin particle formation via the SAS process, particle size was determined mainly by evaporation of the organic solvent into the antisolvent phase. In addition, the mean particle size was increased with increasing drug solution concentration. In this study, from the aspects of particle size and solvent toxicity, acetone was the better organic solvent for controlling nanoparticle formation of atorvastatin calcium.

Original languageEnglish
Pages (from-to)543-547
Number of pages5
JournalChemical and Pharmaceutical Bulletin
Volume60
Issue number4
DOIs
Publication statusPublished - 2012 Apr 1

Fingerprint

Particle Size
Nanoparticles
Particle size
Organic solvents
Acetone
Particle size analysis
Atorvastatin Calcium
Boiling point
Dimethyl Sulfoxide
Pharmaceutical Preparations
Particles (particulate matter)
Toxicity
Evaporation

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Drug Discovery

Cite this

@article{301b60f5deef4e99bf1ac82d291986b1,
title = "Effect of solvent type on the nanoparticle formation of atorvastatin calcium by the supercritical antisolvent process",
abstract = "The aims of this study were to identify how the solvent selection affects particle formation and to examine the effect of the initial drug solution concentration on mean particle size and particle size distribution in the supercritical antisolvent (SAS) process. Amorphous atorvastatin calcium was precipitated from seven different solvents using the SAS process. Particles with mean particle size ranging between 62.6 and 1493.7 nm were obtained by varying organic solvent type and solution concentration. By changing the solvent, we observed large variations in particle size and particle size distribution, accompanied by different particle morphologies. Particles obtained from acetone and tetrahydrofuran (THF) were compact and spherical fine particles, whereas those from N-methylpyrrolidone (NMP) and dimethylsulfoxide (DMSO) were agglomerated, with rough surfaces and relatively larger particle sizes. Interestingly, the mean particle size of atorvastatin calcium increased with an increase in the boiling point of the organic solvent used. Thus, for atorvastatin particle formation via the SAS process, particle size was determined mainly by evaporation of the organic solvent into the antisolvent phase. In addition, the mean particle size was increased with increasing drug solution concentration. In this study, from the aspects of particle size and solvent toxicity, acetone was the better organic solvent for controlling nanoparticle formation of atorvastatin calcium.",
author = "Kim, {Min Soo} and Song, {Ha Seung} and Park, {Hee Jun} and Hwang, {Sung Joo}",
year = "2012",
month = "4",
day = "1",
doi = "10.1248/cpb.60.543",
language = "English",
volume = "60",
pages = "543--547",
journal = "Chemical and Pharmaceutical Bulletin",
issn = "0009-2363",
publisher = "Pharmaceutical Society of Japan",
number = "4",

}

Effect of solvent type on the nanoparticle formation of atorvastatin calcium by the supercritical antisolvent process. / Kim, Min Soo; Song, Ha Seung; Park, Hee Jun; Hwang, Sung Joo.

In: Chemical and Pharmaceutical Bulletin, Vol. 60, No. 4, 01.04.2012, p. 543-547.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of solvent type on the nanoparticle formation of atorvastatin calcium by the supercritical antisolvent process

AU - Kim, Min Soo

AU - Song, Ha Seung

AU - Park, Hee Jun

AU - Hwang, Sung Joo

PY - 2012/4/1

Y1 - 2012/4/1

N2 - The aims of this study were to identify how the solvent selection affects particle formation and to examine the effect of the initial drug solution concentration on mean particle size and particle size distribution in the supercritical antisolvent (SAS) process. Amorphous atorvastatin calcium was precipitated from seven different solvents using the SAS process. Particles with mean particle size ranging between 62.6 and 1493.7 nm were obtained by varying organic solvent type and solution concentration. By changing the solvent, we observed large variations in particle size and particle size distribution, accompanied by different particle morphologies. Particles obtained from acetone and tetrahydrofuran (THF) were compact and spherical fine particles, whereas those from N-methylpyrrolidone (NMP) and dimethylsulfoxide (DMSO) were agglomerated, with rough surfaces and relatively larger particle sizes. Interestingly, the mean particle size of atorvastatin calcium increased with an increase in the boiling point of the organic solvent used. Thus, for atorvastatin particle formation via the SAS process, particle size was determined mainly by evaporation of the organic solvent into the antisolvent phase. In addition, the mean particle size was increased with increasing drug solution concentration. In this study, from the aspects of particle size and solvent toxicity, acetone was the better organic solvent for controlling nanoparticle formation of atorvastatin calcium.

AB - The aims of this study were to identify how the solvent selection affects particle formation and to examine the effect of the initial drug solution concentration on mean particle size and particle size distribution in the supercritical antisolvent (SAS) process. Amorphous atorvastatin calcium was precipitated from seven different solvents using the SAS process. Particles with mean particle size ranging between 62.6 and 1493.7 nm were obtained by varying organic solvent type and solution concentration. By changing the solvent, we observed large variations in particle size and particle size distribution, accompanied by different particle morphologies. Particles obtained from acetone and tetrahydrofuran (THF) were compact and spherical fine particles, whereas those from N-methylpyrrolidone (NMP) and dimethylsulfoxide (DMSO) were agglomerated, with rough surfaces and relatively larger particle sizes. Interestingly, the mean particle size of atorvastatin calcium increased with an increase in the boiling point of the organic solvent used. Thus, for atorvastatin particle formation via the SAS process, particle size was determined mainly by evaporation of the organic solvent into the antisolvent phase. In addition, the mean particle size was increased with increasing drug solution concentration. In this study, from the aspects of particle size and solvent toxicity, acetone was the better organic solvent for controlling nanoparticle formation of atorvastatin calcium.

UR - http://www.scopus.com/inward/record.url?scp=84859474061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859474061&partnerID=8YFLogxK

U2 - 10.1248/cpb.60.543

DO - 10.1248/cpb.60.543

M3 - Article

C2 - 22466739

AN - SCOPUS:84859474061

VL - 60

SP - 543

EP - 547

JO - Chemical and Pharmaceutical Bulletin

JF - Chemical and Pharmaceutical Bulletin

SN - 0009-2363

IS - 4

ER -